3,4-dihydroxyphenylacetic acid has been researched along with Goldblatt Syndrome in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawamura, T | 1 |
| Nakada, T | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and Goldblatt Syndrome
| Article | Year |
|---|---|
Role of dopamine in the striatum, renin-angiotensin system and renal sympathetic nerve on the development of two-kidney, one-clip Goldblatt hypertension.
Topics: 3,4-Dihydroxyphenylacetic Acid; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Corpus Stria | 1996 |